| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.68B | +54.1% |
| Gross profit | ¥0.23B | — |
| Operating income | ¥0.18B | — |
| Net income | ¥0.18B | +1334.1% |
| Gross margin | 33.6% | Net margin 25.9% |
| Revenue Q/Q | +2.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.45B | 66.4% |
| R&D | ¥0.00B | 0.1% |
| SG&A | ¥0.03B | 5.0% |
| Tax & other | ¥0.00B | 0.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中亚股份 ・ 恒实科技 ・ 友讯达 ・ 三德科技 ・ 久之洋 ・ 海波重科 ・ 新迅达 ・ 新光药业 ・ 科大国创 ・ 爱司凯 ・ 世名科技 ・ 辰安科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies